Central Precocious Puberty

18 clinical trials · Condition

Record	Firm	Date
A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Participants With Central Precocious Puberty. (NCT05029622)	Ipsen	2021-08-10
Efficacy and Safety Study of Triptorelin 3-Month Formulation in Chinese Children With Central Precocious Puberty. (NCT04736602)	Ipsen	2021-03-27
A Study to Assess the Safety and Efficacy of Enantone (Leuprorelin) in Central Precocious Puberty (CPP) Among Chinese Participants (NCT02993926)	Takeda	2017-06-24
A Study to Assess the Safety and Efficacy of Leuprorelin in Central Precocious Puberty in Chinese Participants (NCT02427958)	Takeda	2015-08-07
Leuprorelin Acetate DPS (Leuplin DPS) Treatment Quarterly in Patients With Central Precocious Puberty (NCT03316482)	Jin Soon Hwang	2015-06-11
Markers of Pubertal Suppression During Therapy for Precocious Puberty (NCT02006680)	University of Minnesota	2013-12-01
Study of Comprehensive Diagnosis and Treatment for Children Precocious Puberty (NCT02920515)	Ruijin Hospital	2012-09-01
Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty (NCT01467882)	Debiopharm International SA	2012-04-01
The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty (NCT01634321)	Daewoong Pharmaceutical Co. LTD.	2011-07-01
Comparative Validation of the Triptorelin Test for the Diagnosis of CPP in Girls (NCT01278290)	Hospital de Niños R. Gutierrez de Buenos Aires	2009-12-01
Histrelin Subcutaneous Implant in Children With Central Precocious Puberty (NCT00779103)	Endo USA Inc., a Keenova Therapeutics Company	2004-09-01
Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children (NCT00438217)	University of Pisa

Track Central Precocious Puberty automatically

Every clearance here is in the API, with alerts when new ones post.